Methods for treatment of cancer with an anti-tigit antagonist antibody
US-2024424092-A1 · Dec 26, 2024 · US
Composition for preventing or improving inflammation including extract of seed of new soybean cultivar SCEL-1
US11426421B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11426421-B2 |
| Application number | US-201816212116-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2018 |
| Priority date | Jul 5, 2018 |
| Publication date | Aug 30, 2022 |
| Grant date | Aug 30, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are a composition for preventing or improving inflammation, the composition including an extract of a seed of soybean Glycine max (L.) Merrill cultivar SCEL-1, and a method of preventing occurrence of inflammation in a subject or improving inflammation in a subject, the method including injecting the composition to a subject.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a human suffering from atopic dermatitis or chronic obstructive pulmonary disease, the method comprising administering a composition to the human in need thereof, wherein the composition comprises, as an active ingredient, an extract obtained by performing an extraction process on a seed of soybean Glycine max (L.) Merrill cultivar SCEL-1 by using water, C 1 -C 6 alcohol, or a mixture thereof, wherein the extract contains cyanidin-3-O-glucoside, procyanidin B2, and epicatechin, wherein an amount of procyanidin B2 contained in the extract by weight is two times or more than an amount of cyanidin-3-O-glucoside contained in the extract by weight, and wherein a representative sample of the seed is deposited with the Korean Agricultural Culture Collection (KACC), which is an International Depository Authority (IDA) under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purpose of Patent Procedure under the accession number KACC 88002BP on Nov. 8, 2018. 2. The method of claim 1 , wherein a total amount of the cyanidin-3-O-glucoside, procyanidin B2, and epicatechin in the extract is in a range of 2.1% to 3.4% based on a total weight of the extract. 3. The method of claim 1 , wherein the extract comprises a mass ratio of cyanidin-3-O-glucoside:procyanidin B2 to be between 1:2.0 and 1:2.1. 4. The method of claim 1 , wherein an amount of the extract is in a range of 0.005% to 99.9% based on a total weight of the composition. 5. The method of claim 1 , wherein the human is also suffering from skin inflammation. 6. The method of claim 1 , wherein the composition is a food, a cosmetic composition, or a pharmaceutical composition.
Assignees
Inventors
Classifications
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Preparations for care of the skin · CPC title
Magnoliopsida [dicotyledons] · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11426421B2 cover?
- Provided are a composition for preventing or improving inflammation, the composition including an extract of a seed of soybean Glycine max (L.) Merrill cultivar SCEL-1, and a method of preventing occurrence of inflammation in a subject or improving inflammation in a subject, the method including injecting the composition to a subject.
- Who is the assignee on this patent?
- Korea Inst Sci & Tech, Republic Korea Man Rural Dev Admin
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7048. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).